Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer

Monitoring disease progression through imaging is playing an increasingly important role in the treatment of prostate cancer. Here, we report that primary mouse prostate cancer cell lines stably expressing luciferase and tumor biomarkers can be monitored through bioluminescence imaging along with as...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peng, Xu, Naijin, Guo, Kai, Xu, Abai, Takenaka, Fumiaki, Matsuura, Eiji, Liu, Chunxiao, Kumon, Hiromi, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078072/
https://www.ncbi.nlm.nih.gov/pubmed/27105511
http://dx.doi.org/10.18632/oncotarget.8846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078072/
https://www.ncbi.nlm.nih.gov/pubmed/27105511
http://dx.doi.org/10.18632/oncotarget.8846

Ejemplares similares